Potential for drug-drug interaction between vonoprazan and prasugrel on antiplatelet effect assessed by VerifyNow P2Y12 assay in patients with coronary artery disease
3 September 2019 (14:00 - 18:00)
Organised by:
Abstract
About the speaker

Juntendo University Nerima Hospital, Tokyo (Japan)
9 More presentations in this session
Access the full session
The Event
ESC Congress 2019
3 September 2019
14:00 CET
